From the Archives of Our Bodies, Our BlogDrugs & Pharmaceutical Companies Who Paid For That Study? Identifying Conflicts of Interest in Medical Research Read La FDA Reevalúa los Riesgos de los Medicamentos para la Osteoporosis Read FDA Takes Another Look at Osteoporosis Drug Risks Read Safe Cosmetics Act Addresses Gaps in Safety Regulations Read Upcoming Webinar on FDA Drug Approvals and Breast Cancer Read DES: A Story of Doctors Not Knowing Best Read The DES story is about more than a tragedy; it is about a women’s health movement that questioned whether doctors always know best. The DES story is about more than a tragedy; it is about a women’s health movement that questioned whether doctors always know best. What Medicines Are Pregnant Women Taking? Read Healthcare Providers Asked to Help FDA Monitor Pharmaceutical Promotions Read Update on Availability of Compounded Progesterone for Preterm Birth Read Objections Build to Price Hike for Makena, Drug to Prevent Preterm Birth Read Odds and Ends Read More Attention to Potential Risks from Bisphosphonates Read Avastin Follow-Up: Info from the FDA Read FDA Moves to Revoke Approval of Popular Breast Cancer Drug Read Selling Out Medicine: An Up-Close Look at the Pharmaceutical Industry's Influence on Medical Research Read The Sex Drug Chronicles: Flibanserin Evidence Too Flimsy for FDA Approval Read FDA Unveils Next Steps in Transparency Initiative, Public Comment Requested Read "Less is More" Series Highlights Overused Medical Interventions Read Panel de la FDA recomienda vacuna contra el cáncer cervicouterino; Joven de Florida se opone a Gardasil como vía a la ciudadanía Read FDA Announces Program to Study Prescription Drugs in Pregnancy Read 1 2 3 4 5 6 7 8